Russia To Start Clinical Trials Of Betuvaks COVID-19 Vaccine In Early October - Skolkovo
Mohammad Ali (@ChaudhryMAli88) Published September 27, 2021 | 11:20 PM
MOSCOW (UrduPoint News / Sputnik - 27th September, 2021) Clinical trials of the Betuvaks-CoV-2 vaccine against COVID-19, developed by Russian company Betuvaks, will commence in early October, the Skolkovo innovation hub said on Monday.
The Russian Health Ministry authorized the clinical trials earlier in the day. Betuvaks is a Skolkovo resident company.
"The drug only contains surface antigens of the coronavirus, which reduces the protein content and, consequently, its allergenic potency," Skolkovo said in a statement.
The trials will be conducted on 170 volunteers at hospitals in St.
Petersburg and Perm and last until August 2022, according to the developer.
Betuvaks-CoV-2 is a recombinant subunit new generation vaccine based on spherical particles containing surface antigens, or proteins, of the coronavirus, Skolkovo explained.
"The vaccine does not carry genetic material, excessive antigen load, additional preservatives, stabilizers, and non-organic adjuvants, which minimizes the risks of side effects," the statement read.
Pre-clinical trials of the vaccine on animals are said to have shown that it is safe and effective.
Related Topics
Recent Stories
Today Gold Rate in Pakistan 25 April 2024
Mired in crisis, Boeing reports another loss
Session Awarding Ceremony 2024 held at Cadet College Muzaffarabad
Austrian ski great Hirscher to make comeback under Dutch flag
Pakistan, Japan agrees to convene 'Economic Policy Dialogue'
FM Dar conveys deepest sympathy on torrential rains devastation in UAE
Spain PM Sanchez says weighing resignation after wife's graft probe
Tennis: ATP/WTA Madrid Open results - 1st update
Long-lost Klimt portrait auctioned off for 30 mn euros
Osaka seals first win on clay since 2022 in Madrid
Earthquake jolts Karachi
Sindh minister orders operation after attack on police in Ghotki
More Stories From World
-
Star Dudamel brings inclusive vision to New York Philharmonic
40 seconds ago -
Paris dream of swimming in the Seine finally within reach
30 minutes ago -
Portugal's Carnation Revolution, 50 years on
31 minutes ago -
Tough times for Argentine factories as consumers penny-pinch
41 minutes ago -
Use of alcohol and e-cigarettes among youth 'alarming': WHO
41 minutes ago -
Football: Italian Cup result
51 minutes ago
-
Bird flu in humans? Experts see little risk
51 minutes ago -
Car giants vie for EV crown at Beijing's Auto China show
1 hour ago -
Meta profits soar but costs of AI cause worry
1 hour ago -
Tennis: ATP/WTA Madrid Open results - collated
1 hour ago -
Football: French Ligue 1 results - collated
1 hour ago -
Meta sees profits soar in first quarter
1 hour ago